U.S. Medical Equipment Stock News

Why Ituran Location and Control stock is in focus today Ituran Location and Control (ITRN) drew fresh attention after announcing a multi year Software as a Service contract with entities under Israel's Ministry of Transport, centered on nationwide live traffic monitoring. The new contract arrives after a mixed run for Ituran Location and Control shares, with the 1 day share price return of 2.29% and year to date share price return of 24.01% contrasting with a 90 day share price decline of...

Medtronic (MDT) just secured FDA clearance for its LigaSure RAS Maryland jaw device on the Hugo robotic-assisted surgery system. This technical update gives investors fresh detail on the group’s expanding surgical robotics tool kit. Medtronic’s recent news flow has come alongside a clear shift in how the market is pricing the story, with the share price delivering a 16.9% 90 day share price return even though the year-to-date share price return is still down 3.4%, and the 5 year total...

PVH Corp. has seen its share price move around in recent years, and that kind of choppy journey puts a spotlight on a simple question. Is the current US$73.54 price tag adequately backed by the sales the business is generating today and is expected to produce over time? Over the past 5 years the stock has fallen 33.6%, which makes the link between PVH’s current share price and its underlying sales power especially important to scrutinize. The group’s value hinges heavily on how efficiently...

Firefly Aerospace (FLY) is back in focus after a new multi-launch agreement with SSC Space for two Alpha rocket missions from Sweden’s Esrange Space Center, targeting first liftoff no earlier than 2028. Firefly Aerospace’s latest contract lands after a choppy run for the stock. The 1-day share price return of 7.10% and 7-day gain of 3.92% come after a 30-day share price return that declined 16.91% and a 1-year total shareholder return that fell 51.97%, suggesting short-term momentum has...

Steel Dynamics (STLD) shook up expectations after issuing fresh third quarter 2026 earnings guidance, projecting US$5.34 to US$5.38 per diluted share. The company tied that outlook to stronger steel margins, record shipments, and growing aluminum operations. The guidance lands after a sharp move in the share price, with Steel Dynamics closing at US$245.35 following a 1-day share price return of 2.99%. Despite recent softness over the past month and quarter, momentum over longer periods...

Block (NYSE:XYZ) is powering Ideal Nutrition's expansion as the meal-prep retailer moves from 17 to at least 20 locations in the US. Ideal Nutrition has selected Square's unified commerce tools for retail point of sale, franchise management, loyalty programs, payroll, and digital ordering. Store level teams are starting to use Square's AI driven analytics to track customer behaviour and refine product decisions in real time. Ideal Nutrition's national rollout using Square's unified commerce...

NIKE (NKE) has expanded its board to twelve directors and added Alexandre Arnault, a senior LVMH executive, as a new member. That governance shift gives investors a fresh lens on the stock. NIKE shares have risen 1.6% in the last session to about US$36. However, the 30-day share price return is down 9.2% and the year-to-date share price return has fallen 42.5%, while the 1-year total shareholder return is down 47.9%. This points to pressure that board changes and the wider turnaround effort...

PG&E Corporation has seen its share price fall recently, and that slide raises a direct question for income focused investors about how well the current valuation lines up with the utility's dividend stream. With a Dividend Discount Model (DDM) estimate available, the issue is whether the price near US$13 still makes sense when you only look at the cash PG&E may return to shareholders over time. Over the past 5 years, PG&E has delivered a share price gain of 36.5%, which puts real weight on...

Organon (NYSE: OGN) announced FDA acceptance of a supplemental New Drug Application for MIUDELLA, a hormone-free contraceptive device. The company secured exclusive global rights to MIUDELLA under a licensing deal that covers development and commercialization. Organon plans a U.S. commercial launch of MIUDELLA following FDA review, supported by a REMS program focused on provider training. The MIUDELLA sNDA milestone and launch plans matter, but investors should weigh them alongside Organon's...

Pinnacle West Capital (PNW) has called a special investor event, a move that often signals management is ready to address upcoming corporate plans or clarify recent developments that could matter for shareholders. Recent trading tells a mixed story. The share price is about $95.59 after easing 4.6% over 30 days and 6.6% over 90 days. Over a longer horizon, Pinnacle West Capital has delivered a 15.6% 1-year total shareholder return and 63.9% over five years, which may indicate that investors...

Everpure (P) is back in focus after Needham launched coverage, sending the share price up 4.4% and giving investors fresh reason to reassess this data storage specialist. The recent 6.5% 1 day share price return and 10.5% 7 day share price return add to a strong year to date share price return of 50.7%. However, the stock is still down 11.2% on a 30 day share price basis. At the same time, the 3 year total shareholder return of about 200% and 5 year total shareholder return of about 285%...

Pegasystems has had a mixed share price journey, with the stock up 70.7% over the past three years but still carrying some sharp drawdowns more recently. That swing in sentiment puts the focus squarely on one question for investors today: whether the current US$36.07 price is supported by the cash the business is expected to generate. The 70.7% gain over three years means anyone holding Pegasystems for that period has already seen substantial value creation at the share price level, which...

Marvell Technology (MRVL) is back in the spotlight after expanding its multi year agreement with GlobalFoundries to boost silicon germanium chip capacity for high speed optical links inside AI focused data centers. For context, Marvell Technology’s share price has climbed 6.1% over the past week and 11.5% over the past month, even after a 90 day share price return that is down 22.5%, while total shareholder return over five years sits at about 2.9x. Recent catalysts include the expanded...

Baldwin Insurance Group has been in focus after a solid year to date share price run and a proposed take private deal, which naturally puts the spotlight on whether the current valuation can be explained by its sales base. With the stock now trading close to the cash offer level, the question for investors is how much of Baldwin Insurance Group's revenue power is already reflected in the price. The share price is up 34.4% year to date, which raises the stakes on whether that gain is...

Tidewater’s renewed spotlight and capital choices Fresh coverage of Tidewater (TDW) has pulled the offshore service vessel operator back into focus for investors. The discussion now centers on how its global fleet, regional reach, and free cash flow margin might influence future capital allocation. Recent attention on Tidewater comes after a powerful run, with the share price climbing 35.81% over the past 90 days and 68.16% year to date. However, the past month’s share price return of down...

PepsiCo (NasdaqGS:PEP) is flagged in a new industry report as the most exposed global food brand to GLP-1 weight loss drugs. The study highlights material risk for PepsiCo snack lines such as Lay's, linked to potential shifts in calorie-dense snacking habits. The same report points to possible upside for beverages including Gatorade and Aquafina as consumption patterns evolve over multiple years. The identification of GLP-1 weight loss drugs as a major swing factor for PepsiCo brand mix...

Chubb has delivered a strong multi year share price run, and the question for investors now is whether the returns it earns on its capital are enough to justify where the stock trades today. Over the past 5 years Chubb has returned 107.1%, which puts real weight on whether the business is generating sufficiently strong returns on the capital it invests. The appointment of Sean Ringsted as Chief Scientist and Executive Vice President focuses the insurer more tightly on artificial...

Minerals Technologies has scheduled its 2026 Investor Day for September 22 at its Bethlehem, Pennsylvania research and development center, featuring executive presentations and a facility tour that focus on the group’s approach to innovation, new growth initiatives, and long term value creation themes. The decision to spotlight research capabilities and product line leadership at the R&D hub signals an effort to connect Minerals Technologies’ technical pipeline, including higher value...

The U.S. House passing the Ratepayer Protection Act put fresh attention on how data centers will pay for power upgrades. Bloom Energy (BE) quickly entered that conversation with detailed claims around its 800V DC native fuel cell system for AI sites. Bloom Energy has been on a sharp run, with a 1 day share price return of 3.98%, a 7 day move of 8.62% and a 30 day gain of 34.33%. However, the 90 day share price return declined 14.64%, so short term momentum is rebuilding after a setback. Scan...

Dell Technologies (DELL) just closed out a multiyear buyback, retiring 204.4 million shares for US$19.6b, even as record AI server demand, rising revenue guidance, and strong earnings revisions keep the stock firmly in the spotlight. The recent 4.46% 1 day share price return, on top of a 16.14% 7 day move and 25.55% 30 day share price return, shows momentum building around Dell Technologies as investors react to record AI server orders, raised revenue guidance and expanding partnerships. That...

On 18 September 2026, Starbucks (NasdaqGS:SBUX) was reported to be considering a sale of its majority stake in Starbucks Japan. The potential deal could value the Japanese business at around US$3b, according to people familiar with the discussions. Starbucks Japan represents the group's largest company operated market outside the US and accounts for nearly 9% of its global stores. The possible sale of Starbucks' majority interest in Japan sits alongside broader shifts in how the chain...

Recent move in Agnico Eagle Mines stock Agnico Eagle Mines (AEM) gained 2.97% in its latest session, outpacing the S&P 500, after projections pointed to a 13.43% year over year rise in next quarter EPS. The recent 1-month share price return of 7.72% and 90-day share price return of 20.83% indicate momentum in Agnico Eagle Mines, with the 1-year total shareholder return of 31.59% and very large 3- and 5-year total shareholder returns highlighting a longer period of strong compounding. Look...

Intellia Therapeutics (NTLA) is back in focus after the FDA accepted its Biologics License Application for lonvo-z and granted Priority Review, a key regulatory step for this CRISPR-based hereditary angioedema therapy. Investors have responded quickly to the lonvo-z update, with Intellia Therapeutics’ share price gaining 6.7% over the past day and posting a 33.12% year-to-date share price return, although the 1-year total shareholder return has declined 23.9%, pointing to momentum rebuilding...

Edwards Lifesciences has delivered a mixed share price story, with a long term decline sitting alongside shorter term gains. That raises a sharp question about what investors are really paying for in its cash flows today. With fresh policy support for its heart valve procedures now in place, the gap between the stock price and the cash it can generate has become an important issue for anyone looking at Edwards Lifesciences stock. Over the past 5 years, the share price declined 27.1%. This...